National Health (Immunisation Program — Designated Vaccines) Amendment Determination (No. 3) 2019 (Cth)
National Health (Immunisation Program — Designated Vaccines) Amendment Determination (No. 3) 2019
I, Hope Peisley delegate of the Minister for Health, make the following Determination.
Dated 17 December 2019
Ms Hope Peisley
Acting Assistant Secretary
Office of Health Protection
Chief Medical Officer Group
Department of Health
Contents
1 Name........................................................................................................................................ 1
2 Commencement........................................................................................................................ 1
3 Authority.................................................................................................................................. 1
4 Schedules................................................................................................................................. 1
Schedule 1—Amendments 2
National Health (Immunisation Program — Designated Vaccines) Determination 2014 (No. 1) 2
1 Name
This instrument is the National Health (Immunisation Program — Designated Vaccines) Amendment Determination (No. 3) 2019.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
| Commencement information | ||
| Column 1 | Column 2 | Column 3 |
| Provisions | Commencement | Date/Details |
| 1. The whole of this instrument | On the day after this instrument is registered. | |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under subsection 9B(2) and 9B(5) of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Immunisation Program — Designated Vaccines) Determination 2014 (No. 1)
[1] Subsection 7(8)
Repeal the subsection, substitute:
(8) For item 207B of Schedule 1, a designated vaccine mentioned in that item may be provided to any of the following:
(a) a person who is at least 65 years old or
(b) an Aboriginal or Torres Strait Islander person who is at least 6 months old; or
(c) a child who is at least 6 months old but less than 5 years old; or
(d) a person who is at least 6 months old and who:
(i) has cardiac disease including cyanotic congenital heart disease, coronary artery disease and congestive heart failure; or
(ii) has a chronic respiratory condition including suppurative lung disease, bronchiectasis, cystic fibrosis, chronic obstructive pulmonary disease, chronic emphysema and severe asthma; or
(iii) has another chronic illness requiring regular medical follow‑up or hospitalisation in the preceding year, including diabetes mellitus, chronic metabolic diseases, chronic renal failure, haemoglobinopathies and impaired immunity (including drug‑induced immune impairment); or
(iv) has a chronic neurological condition, including multiple sclerosis, spinal cord injuries, seizure disorders or other neuromuscular disorders; or
(v) has impaired immunity, including HIV infection; or
(e) a person who is at least 6 months old but is less than 11 years old and is receiving long‑term aspirin therapy; or
(f) a woman who is pregnant.
[2] Part 2 of Schedule 1 (table item 207B, column headed “Number and timing of doses”)
Omit “3 years”, substitute “aged 6 months”.
[3] Part 2 of Schedule 1 (after table item 207F)
Insert:
207G Vaccine
Influenza
Circumstances
Vaccine may be provided to a person who is at least 65 years of age.
Fluad Quad Injection (0.5mL) 1 dose per calendar year.
0
0
0